RxDoctor Payments DataLook up a doctor →

Kayde Moore

Physician Assistant · Brunswick, GANPI 1891184453

Payments from drug & device makers

$17,486in general payments, 2019–2025

Across 739 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • Merck$830
  • Takeda Pharmaceuticals U.S.A., Inc.$756
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis59$1,812
AstraZeneca(2 entities)46$1,202
Pfizer56$1,021
Johnson & Johnson34$1,016
Merck34$830
Takeda Pharmaceuticals U.S.A., Inc.21$756
Gilead(2 entities)25$657
E.r. Squibb & Sons, L.L.C.28$459
Incyte Corporation17$433
Eisai Inc.21$412
Amgen26$405
Seagen Inc.16$403
Sanofi14$398
Bristol Myers Squibb20$380
Astellas Pharma US Inc9$357
Bayer16$332
Regeneron Healthcare Solutions, Inc.15$325
GSK16$323
AbbVie12$317
Taiho Oncology, Inc.12$313
Daiichi Sankyo Inc.15$310
Genentech USA, Inc.15$305
Sobi, Inc11$297
Lilly USA, LLC13$277
Exelixis Inc.11$242
Boehringer Ingelheim9$226
Tersera Therapeutics LLC9$205
G1 Therapeutics, Inc.6$185
Pharmacosmos Therapeutics Inc.10$180
Stemline Therapeutics Inc.7$171
Puma Biotechnology, Inc.8$166
Octapharma USA, Inc.7$157
Servier Pharmaceuticals LLC8$149
Rigel Pharmaceuticals, Inc.8$147
Karyopharm Therapeutics Inc.3$146
Jazz Pharmaceuticals Inc.7$145
Mirati Therapeutics, Inc.7$137
Janssen Scientific Affairs, LLC1$137
Array Biopharma Inc10$136
Beigene USA, Inc.7$118
Pharmaessentia USA Corporation5$102
Boston Scientific1$95
Menarini Silicon Biosystems, Inc.2$83
Pharmacyclics LLC, An Abbvie Company5$81
Beone Medicines USA, Inc.4$74
Recordati_rare_diseases_inc.3$70
Deciphera Pharmaceuticals Inc.3$68
CSL Behring3$66
Novocure Inc.4$60
ADC Therapeutics America, Inc.3$56
Morphosys, US Inc.3$55
Tolmar, Inc.2$50
Springworks Therapeutics, Inc.2$47
Spectrum Pharmaceuticals Inc.2$41
Acrotech Biopharma Inc.2$40
AVEO Pharmaceuticals, Inc.2$39
ADMA Biomanufacturing LLC2$39
Ipsen Biopharmaceuticals, Inc2$37
Legend Biotech USA Inc.2$37
Syndax Pharmaceuticals, Inc.2$34

How this compares

$17,486 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia →

Medicare billing

Part B allowed, 2024
$95,809
Medicare patients
87
Services billed
3,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Brunswick

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →